News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances Caitlin E. Cox September 19, 2022
News Conference News TCT 2017 Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock Yael L. Maxwell November 09, 2017